Colgate-Palmolive stock
CLNYSEColgate-Palmolive Company, Consumer DefensiveISIN US1941621039
72Score 72 out of 100, Strong
Price and trend
83 / 100
Price history
+25% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 8.5% above it.
Since November 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 61).
The price is 1.3% below its 52-week high. Largest decline in 20 years: 32% (January 2008 to October 2008).
Chart figures for advanced users
- SMA 50$90.77
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$90.24
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)61
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$76.11
- The lowest closing price of the last twelve months.
- Resistance$99.14
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Colgate-Palmolive Company belongs to the Household & Personal Products industry (United States) and, with a market value of $77.82B, is number 4 of 39 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $20.38B (up 1.4% year on year) and earnings of $2.13B (down 26.2%).
- For fiscal 2026, analysts expect on average revenue of $21.41B (up 5%) and adjusted earnings per share of $3.92 (up 6.1%).
Show more
- MEQIRI Score 72 out of 100 (Strong): rank 43 of 295 in Consumer Defensive, median 62.
- Our model puts fair value at $85.54, with the price 15% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Reliable dividendNo dividend cut for over 53 years.Capital allocation 87
- High return on capitalReturn on invested capital 31.7% in fiscal 2025, Household & Personal Products median 9%.Profitability 85
- Earnings turn into cashFree cash flow 185% of earnings over the last 12 months.Fundamentals 100
Weaknesses
- High debtDebt 12.06 times equity (latest quarter), Household & Personal Products median 0.7.Stability 55
- Margin fallingOperating margin 16.2%, average of the prior years 21.8% (to 2024).
Its standout strengths are fundamentals and capital allocation, while valuation and growth hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk low
How well MEQIRI warnsOne of the 30% with the lowest crash risk among stocks ranked 101 to 1,000.
From 2016 to 2025, 9 in 100 such stocks fell 30% or more within a year, against a group average of 15 in 100.
What lowers it
- solid fundamentals
- price near its 52-week high
Valuation
Valuation signal
Modestly overvaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $71.29 and expensive above $106.93 (uncertainty low, based on the price swings of the past year).
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $71.56, at 7.8% it would be $106.50.
Valuation metrics
From the cash-flow model alone; the profit includes one-off items, so there is no industry value.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 5.9% on the twelve months before. Revenue has stayed largely stable since 2006.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 60%, operating 16%, net 10%.
Debt & balance sheet
latest quarterMeaningfully leveraged, but the interest bill is comfortably covered.
Earnings
- Next earnings
- 29 Jan 2027in 78 days
- Last reported
- 30 Oct 2026EPS reported $0.97 (expected $0.93)above expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $3.92+1.4%
- Revenue
- $21.41B−0.1%
- Earnings per share
- $4.10+0.2%
- Revenue
- $21.9B−0.9%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: −1.9%2026 gross margin guidance raised to roughly flat for the year; higher raw material costs and tariffs are expected in the second half.
“We've increased our gross margin guidance to roughly flat for the year, but we do have to keep in mind that we do expect the higher raw materials and tariffs will be higher in the second half of the year than they were in the second quarter.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 31 Jul 2026 (fiscal Q2 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases in the last 6 months. 6 insiders sold, $37.92M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Norrington Lorrie MSale
5 Nov 2026, Board
- Shares
- 4,170
- Price
- $99.31
- Value
- $414,123
- Wallace Noel R.Sale
5 Nov 2026, Chairman, President & CEO
- Shares
- 20,000
- Price
- $100.26
- Value
- $2.01M
- Tsourapas PanagiotisSale
4 Nov 2026, COO, CD, EMEA, APac, Skin
- Shares
- 19,938
- Price
- $98.74
- Value
- $1.97M
Show 6 more
- Hazlin JohnSale
4 Nov 2026, Chief Growth Officer
- Shares
- 23,376
- Price
- $99.15
- Value
- $2.32M
- Tsourapas PanagiotisSale
24 Aug 2026, COO, CD, EMEA, APac, Skin
- Shares
- 10,000
- Price
- $92.05
- Value
- $920,477
- Cahill John TSale
6 Aug 2026, Board
- Shares
- 4,170
- Price
- $93.37
- Value
- $389,358
- Wallace Noel R.Sale
5 Aug 2026, Chairman, President & CEO
- Shares
- 161,021
- Price
- $92.52
- Value
- $14.9M
- Wallace Noel R.Sale
4 Aug 2026, Chairman, President & CEO
- Shares
- 161,021
- Price
- $91.92
- Value
- $14.8M
- Malcolm GregorySale
15 May 2026, EVP and Controller
- Shares
- 2,300
- Price
- $88.44
- Value
- $203,412
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Colgate-Palmolive
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
295 rated companies in Consumer Defensive
- This company
- 72
- Sector median
- 62
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Household & Personal Products
The next larger and next smaller companies by market value
- Procter & GamblePG $388.62B73
- L'OréalOR.PA $265.05B78
- UnileverUL $141.67B66
- Hindustan UnileverHINDUNILVR.NS $50.72B69
- Reckitt Benckiser Group3RB.DE $48.2B71
- Estée Lauder CompaniesEL $40.7B54
- Henkel AG & Co. KGaAHEN3.DE $39.46B70
- Kimberly-ClarkKMB $36.2B68
ETFs that hold Colgate-Palmolive
Held by 110 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares MSCI World Consumer Staples Sector ESG UCITS ETF USD3SUE | 3.85% | 0.18% | €100.45M |
| iShares S&P 500 Consumer Staples Sector UCITS ETF2B7D | 2.35% | 0.15% | €518.36M |
| State Street SPDR S&P U.S. Consumer Staples Select Sector UCITS ETF (Acc)ZPDS | 2.35% | 0.15% | €342.88M |
Show 5 more
| Xtrackers MSCI USA Consumer Staples UCITS ETF 1DXUCS | 2.29% | 0.12% | €107.01M |
| Franklin Global Quality Dividend UCITS ETFFLXX | 2.06% | 0.30% | €127.44M |
| Xtrackers MSCI World Consumer Staples UCITS ETF 1CXDWS | 1.51% | 0.25% | €965.83M |
| iShares Edge MSCI USA Minimum Volatility Advanced UCITS ETFMVEA | 1.37% | 0.20% | €117.82M |
| iShares Edge S&P 500 Minimum Volatility UCITS ETFIBCK | 1.24% | 0.20% | €1.97B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 23 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.